Ivivi Technologies, Inc. Signs New Three Year Contract with Regency Hospital to Facilitate the Expanded Use of our Roma3 Device for the Treatment of Chronic Wounds

NORTHVALE, N.J.--(BUSINESS WIRE)--Ivivi Technologies, Inc. (NASDAQ:IVVI), a leader in non-invasive, electrotherapeutic technologies, today announced that it has signed a new three year contract with Regency Hospital Company, a leading owner/operator of Long Term Acute Care (LTAC) hospitals across the United States. The new contract will facilitate Regency’s expanded use of our Roma3 pulsed electromagnetic field (PEMF) device for the treatment of chronic wounds. Under the terms of the agreement, Ivivi will provide Regency facilities with several solution based packages that are priced using a fixed monthly rental rate per facility versus the previous agreements’ per unit rental rate.
MORE ON THIS TOPIC